"TONIGHT AT 7PM: President Trump, Dr. [Mehmet] Oz, and National Design Studio Director Joe Gebbia will be officially unveiling TrumpRx — a state of the art website for Americans consumers to purchase low cost prescription drugs," White House Press Secretary Karoline Leavitt wrote on the social media platform X.
You can watch the event here.
The Trump administration announced plans to launch its TrumpRx website in September, with administration officials saying at the time that the platform would cut out intermediaries and offer drugs "often at full MFN, and always at lower prices than currently available."
Most Favored Nation, or MFN, refers to Trump's push to have drug companies offer drugs in the U.S. at the lowest price they are sold in other countries.
A senior administration official previously specified that "the government is not getting into the drug distribution business."
"Rather, this is a convening site where Americans can come and know that this is a place where they can go direct-to-consumer and access the lowest prices available through the President's MFN initiative," the official added.
The platform will offer some of the medications manufactured by companies that have entered into MFN pricing agreements with the administration.
These include drugmakers like Pfizer, AstraZeneca, Eli Lilly, Novo Nordisk, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead Sciences, GlaxoSmithKline, Merck & Co., Novartis and Sanofi.
The administration has offered some hints at what the TrumpRx.gov platform will look like. Injectable and infusion products, like Novo Nordisk's star product Ozempic, will not be available on the website as an official said it would not be "clinically appropriate" to sell those types of products without a provider present.
Health officials have also indicated the platform will not accept insurance, seeking to bypass those companies.
No comments:
Post a Comment